California becomes first state to ban ‘excited delirium’ diagnosisGovernor Gavin Newsom signed a bill to stop authorities relying on a controversial diagnosis its critics say simply does not exist

Clinical features of delirious mania: a series of five cases and a brief literature reviewLittle is known about the cause and psychopathology of delirious mania, a type of disorder where delirium and mania occur at the same time. This condition still has no formal diagnostic classification. To provide more information about this potentially ...

First of all, delirium is not a transitory state. It is permanent. Excited forms of delirium have been prevalent historically and still today. This is a move to quell police unrest, and it is so disturbing, especially because delirious states are so common. Please see to it that this coward is removed from office immediately. You are not just murderous, you are murdering. This has to stop. This will not go on. You are not to kill people? You need to be arrested right now. You killed someone.

Everyone protects each other, and no one gives a damn really and it's not human nature not to care, it feels good to get away with hurting others, and it's the truth, you piece of shit.

$46.16 billion of its total revenue

The company then used those patents to file "sham lawsuits" against generic drugmakers to prevent them from launching their own versions of Pomalyst, the lawsuit said.

Bristol Myers Squibb on Friday sued over Medicare's new powers to slash drug prices,

Pomalyst is a cancer drug, by Bristol-Myers Squibb.

Second, the Government alleged that, from 2002 through the end of 2005, BMS knowingly promoted the sale and use of Abilify, an atypical antipsychotic drug, for pediatric use and to treat dementia-related psychosis, both “off-label” uses. The Food and Drug Administration has approved Abilify to treat adult schizophrenia and bi-polar disorder, but has not approved the use of Abilify for children and adolescents or for geriatric patients suffering from dementia-related psychosis. Indeed, the FDA has mandated that the package for Abilify carry a “black box” warning concerning its use in the treatment of dementia-related psychosis. Nonetheless, BMS directed its sales force to call on child psychiatrists and other pediatric specialists, and the sales force then urged physicians and others providers to prescribe Abilify for pediatric patients. BMS also created a specialized long term care sales force that called almost exclusively on nursing homes, where dementia-related psychosis is far more prevalent than schizophrenia or bipolar disorder.

=Abilify has been linked to a 7-fold increased risk of type-2 diabetes

Blockbuster drug Abilify nears Judgment Day over compulsive gambling, sexAfter three bellwether cases settle, hundreds near deadline for “global settlement.”

Bristol-Myers to pay $19.5 million in Abilify off-label marketing settlementAlmost a decade after settling up Abilify marketing allegations with the U.S. Justice Department, Bristol-Myers Squibb agreed to pay $19.5 million to settle similar claims at the state level. | Years after wrapping up Abilfy marketing allegations with the U.S. Justice Department, Bristol-Myers Squibb agreed to pay $19.5 million to settle similar claims at the state level.

Abilify Dosage Guide: What’s the Recommended Abilify Dosage? - GoodRxAbilify is a medication for mood disorders. The recommended Abilify dosage depends on your health needs and other medications you may be taking.

Association Between Antipsychotic Medication Use and DiabetesThe prevalence of diabetes is 2–3-fold higher in people with severe mental illness than the general population. There are concerns that antipsychotics increase the risk of diabetes. This review will examine the latest epidemiological studies linking ...

Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuitBristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal tactics to maintain its monopoly on blockbuster blood cancer drug Pomalyst for years after it should have faced generic competition.

Bristol Myers loses bid to toss $6.4B CVR lawsuit tied to Celgene takeover, Breyanzi approvalA U.S. federal court on Friday shot down Bristol Myers Squibb’s motion to dismiss an investor lawsuit connected to its $74 billion Celgene buyout. | A U.S. federal court on Friday shot down Bristol Myers Squibb’s motion to dismiss an investor lawsuit connected to its $74 billion Celgene buyout.

Bristol-Myers Squibb to Pay $75 Million to Resolve False Claims Act Allegations of Underpayment of Drug Rebates Owed Through Medicaid

Bristol-Myers to pay $150M in settlementBristol-Myers Squibb will pay $150 million to settle charges that it manipulated its inventory of medicines in a fraudulent scheme to inflate earnings and meet Wall Street targets, the SEC said Wednesday.

FBI agents had sex with prostitutes overseas, then denied it in lie-detector testsAn official probe was launched after the FBI raised the alarm that “multiple then FBI officials solicited, engaged in, and/or procured commercial sex,” a DOJ report said Tuesday.

Bristol Myers Squibb Company Pays $75 Million Over Allegations of Medicaid Fraud - Walden Macht & Haran LLPBristol Myers Squibb Company Pays $75 Million Over Allegations of Medicaid Fraud U.S. Department of Justice Announces Settlement Today New York, NY, April 1, 2021...

Bristol-Myers Execs Accused of FraudTwo former Bristol-Myers Squibb Co. executives defrauded investors by improperly accounting for $1.5 billion in revenue in 2000 and 2001, the Securities and Exchange Commission said Monday.

Brown Announces $23 Million Drug Price Settlement With Bristol Myers-SquibbLOS ANGELES--Attorney General Edmund G. Brown Jr. today announced that California will receive $23 million of a $515 million nationwide settlement with Bristol-Myers Squibb. The settlement resolves allegations that the company reported “grossly inflated” drug wholesale prices to California’s Medicaid program in an effort to maintain its market share of prescription drugs. “The Medi-Cal system requires companies to accurately report drug prices to the state,” Attorney General Brown said.

Bristol-Myers Squibb to Pay $19.5 Million for Alleged Improper Drug Marketing to Encourage Prescriptions to Children, Elderly

BOSTON - Resolving allegations that it improperly marketed an antipsychotic drug to children and elderly patients, Bristol-Myers Squibb Company (BMS) has agreed to pay a total of $19.5 million in a multistate settlement, including more than $400,000 to Massachusetts, Attorney General Maura Healey announced today.

UPDATE 3-Bristol-Myers settles US charges for $515 millionBristol-Myers Squibb Co <BMY.N> has agreed to pay more than $515 million to settle fraud allegations involving kickbacks to doctors and inflated drug prices, the U.S. Justice Department said on Friday.

Abilify: America’s Once Best-Selling Drug Now Offers a Classic Tale of Big Pharma Greed - Legal ReaderWhat do you do if your pharmaceutical drug lacks a clear competitive advantage and is connected to a long list of side effects? If you are Bristol-Myers Squibb with its Abilify, you spend millions on consumer and physician advertising, stay silent about the drug’s risks, and trump up its benefits. This is Abilify’s story, a

Abilify Lawsuits - Fatal Heart-Rhythm, Abilify Side EffectsAbilify Side Effects May Cause Fatal Heart-Rhythm. On April 13, 2004, the U.S. FDA instructed Bristol-Myers Squibb to notify health care professionals.

Bristol-Myers Squibb Pays $19 Million in Multistate Settlement for Abilify’s Illegal MarketingIn a $19 million Abilify settlement, Bristol-Myers Squibb was found guilty of illegally marketed the antipsychotic for unapproved uses.

Lawsuits fail to stem flow of antipsychotic pills to kidsFlorida's Department of Juvenile Justice has continued giving children antipsychotic pills despite a series of lawsuits filed against the drugs' makers in the past three years. The cases sometimes …

How aripiprazole’s promise for treating autism fell shortAripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade's worth of data suggests that is not true.

this is not poetry. this is not poetry. this is not poetry. this is not poetry. this is not poetic enough for your lying ass?

Google Sites

Report abuse